The World Anti-Doping Agency (WADA) has released an advisory cautioning athletes to be aware of the black market substance GW501516.
GW501516 was a developmental drug that was withdrawn from research by the pharmaceutical company and terminated when serious toxicities were discovered.
More information on the WADA advisory can be found on its website.
Under legislation ASADA has restrictions around what and when it can talk about operational matters.
We understand that at times this can lead to frustrations, but the legislation has clear and tight controls to ensure that people under review have their privacy assured throughout an investigation and result management process.
Due to the level of interest in the current investigation into doping in sport, we have decided to put up on the ASADA website responses to a series of Frequently Asked Questions (FAQs). These responses only include information we can publicly disclose. We will review these FAQs from time to time to address, where possible under legislation, misinformation we come across in the public domain.
It’s time for Registered Testing Pool (RTP) athletes to let ASADA know where they are going to be over the next three months (January to March 2013).
RTP athletes have until 7 December 2012 to get their whereabouts information into ASADA.
Whereabouts can be filed online by the athlete, or by an authorised representative. If athletes are unable to submit their whereabouts online, they should contact ASADA’s Athlete Services Unit by email at email@example.com, or by phone on 13 000 ASADA (27232), or if ringing from overseas on +61 2 6222 4200.
Why is whereabouts important to sport? Conducting out-of-competition testing without notice to athletes has become one of the most powerful means of deterring and detecting doping in sport. Accurate whereabouts information is crucial to ensure the efficiency of ASADA’s anti-doping programs, which are designed to protect the integrity of sport and to protect clean athletes.
Australia has not been immune to the fallout from the United States Anti-Doping Agency’s investigation into the U.S. Postal Service Pro Cycling Team. Since the release of the report in October two prominent Australian cycling figures have admitted to doping during their sporting career.
At ASADA we know that it does not end here. But knowing and having the information to act on are two different things.
The days of remaining silent are over.
The days of fearing the truth getting out are over.
The days of protecting people in the wrong are over.
ASADA is appealing to anyone with information about doping in cycling, past or present, to come forward. It doesn’t matter how little information someone provides, it could be a piece of a puzzle that leads to a doping athlete being caught, or a doping program being shut down.
The United States Anti-Doping Authority (USADA) has sent the Reasoned Decision and supporting information in the Lance Armstrong case to the International Cycling Union, the World Anti-Doping Agency (WADA), and the World Triathlon Corporation.
USADA’s statement and full documentation in the case is available here: tinyurl.com/9yttk3q
A statement from WADA President John Fahey is available through the following link: bit.ly/RPUcoW
Media reports in today’s Melbourne Age and Sydney Morning Herald have incorrectly reported that the Australian Sports Anti-Doping Authority (ASADA) ‘approves’ the method referred to as Orthokine therapy.
ASADA’s primary role is to apply the World Anti-Doping Code and the World Anti-Doping Agency’s (WADA) Prohibited List in Australia.
WADA is responsible for establishing what substances or methods are prohibited in sport.
ASADA can only advise Australia’s sporting community of Orthokine’s status in sport as ruled by WADA.
WADA has previously advised ASADA that it considers Orthokine a variation of the Platelet-Derived Preparations (PRP) method, commonly referred to as blood spinning.
Under WADA’s Prohibited List, Orthokine is not prohibited for use in sport.
Today’s athlete has many competing priorities: sport, family, work, social commitments, school, university, bills, health, diet and training to name a few. But what priority do athletes, who compete in a sport with an anti-doping policy, place upon educating themselves on their anti-doping rights and responsibilities?
ASADA has released more detailed results of its independent 2012 stakeholder research, focussing on education.
The research is completed and analysed by our research contractor, Orima, and is designed to collect opinions from athletes, support personnel and sporting organisations about ASADA and anti-doping.